A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs

Citation
Jp. Krise et al., A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs, J PHARM SCI, 88(9), 1999, pp. 922-927
Citations number
30
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACEUTICAL SCIENCES
ISSN journal
00223549 → ACNP
Volume
88
Issue
9
Year of publication
1999
Pages
922 - 927
Database
ISI
SICI code
0022-3549(199909)88:9<922:ANPAFT>2.0.ZU;2-7
Abstract
Quaternary amine prodrugs resulting from N-phosphonooxymethyl derivatizatio n of the tertiary amine functionality of drugs represents a novel approach for improving their water solubility. Separate reports have demonstrated th e synthetic feasibility and rapid and quantitative prodrug to parent drug c onversion in rats and dogs. This work is a preliminary evaluation of the ph ysicochemical and in vitro enzymatic reversion properties of selected prodr ugs. The loxapine prodrug had over a 15 000-fold increase in aqueous solubi lity relative to loxapine free base at pH 7.4. The loxapine prodrug was als o shown to be quite stable at neutral pH values. The time for degradation p roduct (parent drug) precipitation from an aqueous prodrug formulation woul d be expected to dictate the shelf life. Using this assumption, together wi th solubility and elevated temperature chemical stability studies, the shel f life of a parenteral formulation of the loxapine prodrug was projected to be close to 2 years at pH 7.4 and 25 degrees C. In addition, the prodrugs of cinnarizine and loxapine have been shown to be substrates for alkaline p hosphatase, an enzyme found throughout the human body, and revert to the pa rent compound in its presence. The results from these evaluations demonstra te that the derivatives examined have many of the ideal properties required for potential clinical application.